China: In a new study conducted by Junxiang Chen and the team, it was found that the number of unfavorable outcomes related to diabetes that long-term glycemic variability (GV) was associated with.
Researchers at NuraLogix, a global leader in HealthTech AI, announced today that they have developed AI models that can predict a person's risk of HbA1C levels and Fasting Blood Glucose levels being above a significant clinical threshold for pre-diabetes.